nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0839	0.107	CbGbCtD
Zafirlukast—ABCG2—Dactinomycin—uterine cancer	0.0828	0.106	CbGbCtD
Zafirlukast—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0585	0.0747	CbGbCtD
Zafirlukast—ABCG2—Carboplatin—uterine cancer	0.0556	0.071	CbGbCtD
Zafirlukast—CYP2C8—Progesterone—uterine cancer	0.0556	0.0709	CbGbCtD
Zafirlukast—ABCG2—Etoposide—uterine cancer	0.0467	0.0596	CbGbCtD
Zafirlukast—CYP2C19—Progesterone—uterine cancer	0.0466	0.0595	CbGbCtD
Zafirlukast—PTGS1—Etoposide—uterine cancer	0.0431	0.055	CbGbCtD
Zafirlukast—CYP1A2—Progesterone—uterine cancer	0.043	0.0549	CbGbCtD
Zafirlukast—CYP2C9—Progesterone—uterine cancer	0.0388	0.0495	CbGbCtD
Zafirlukast—CYP2D6—Progesterone—uterine cancer	0.0355	0.0453	CbGbCtD
Zafirlukast—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.034	0.0434	CbGbCtD
Zafirlukast—CYP2E1—Etoposide—uterine cancer	0.0333	0.0425	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—uterine cancer	0.0319	0.0407	CbGbCtD
Zafirlukast—CYP2C8—Etoposide—uterine cancer	0.0249	0.0318	CbGbCtD
Zafirlukast—CYP3A4—Progesterone—uterine cancer	0.0225	0.0288	CbGbCtD
Zafirlukast—CYP1A2—Etoposide—uterine cancer	0.0193	0.0246	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—uterine cancer	0.0108	0.0138	CbGbCtD
Zafirlukast—CYP3A4—Etoposide—uterine cancer	0.0101	0.0129	CbGbCtD
Zafirlukast—CYP3A4—Doxorubicin—uterine cancer	0.00688	0.00878	CbGbCtD
Zafirlukast—CYSLTR2—female reproductive system—uterine cancer	0.00588	0.128	CbGeAlD
Zafirlukast—Glyburide—ABCC9—uterine cancer	0.00546	1	CrCbGaD
Zafirlukast—PTGS1—oviduct—uterine cancer	0.00289	0.063	CbGeAlD
Zafirlukast—CYSLTR1—smooth muscle tissue—uterine cancer	0.00287	0.0627	CbGeAlD
Zafirlukast—CYSLTR1—mammalian vulva—uterine cancer	0.00259	0.0564	CbGeAlD
Zafirlukast—CYSLTR1—uterus—uterine cancer	0.00246	0.0538	CbGeAlD
Zafirlukast—CYSLTR1—female reproductive system—uterine cancer	0.00221	0.0483	CbGeAlD
Zafirlukast—CYSLTR1—vagina—uterine cancer	0.002	0.0437	CbGeAlD
Zafirlukast—PTGS1—artery—uterine cancer	0.00191	0.0417	CbGeAlD
Zafirlukast—Hepatic function abnormal—Progesterone—uterine cancer	0.00164	0.0112	CcSEcCtD
Zafirlukast—Swelling—Progesterone—uterine cancer	0.00163	0.0111	CcSEcCtD
Zafirlukast—Hepatic failure—Progesterone—uterine cancer	0.0016	0.0109	CcSEcCtD
Zafirlukast—Injury—Progesterone—uterine cancer	0.00156	0.0107	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.0102	CcSEcCtD
Zafirlukast—Swelling—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0101	CcSEcCtD
Zafirlukast—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.0099	CcSEcCtD
Zafirlukast—Infection—Carboplatin—uterine cancer	0.00134	0.00913	CcSEcCtD
Zafirlukast—Liver function test abnormal—Progesterone—uterine cancer	0.00133	0.00907	CcSEcCtD
Zafirlukast—Hepatotoxicity—Etoposide—uterine cancer	0.00131	0.00896	CcSEcCtD
Zafirlukast—CYSLTR1—lymph node—uterine cancer	0.0013	0.0283	CbGeAlD
Zafirlukast—Numbness—Etoposide—uterine cancer	0.00122	0.00835	CcSEcCtD
Zafirlukast—Abdominal discomfort—Progesterone—uterine cancer	0.00119	0.00814	CcSEcCtD
Zafirlukast—Sensory loss—Etoposide—uterine cancer	0.00117	0.00799	CcSEcCtD
Zafirlukast—Pain—Carboplatin—uterine cancer	0.00115	0.00786	CcSEcCtD
Zafirlukast—Hepatic failure—Dactinomycin—uterine cancer	0.00113	0.00772	CcSEcCtD
Zafirlukast—ABCG2—myometrium—uterine cancer	0.00111	0.0242	CbGeAlD
Zafirlukast—Neuropathy peripheral—Progesterone—uterine cancer	0.00109	0.00742	CcSEcCtD
Zafirlukast—Jaundice—Progesterone—uterine cancer	0.00108	0.00738	CcSEcCtD
Zafirlukast—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00737	CcSEcCtD
Zafirlukast—Body temperature increased—Carboplatin—uterine cancer	0.00106	0.00726	CcSEcCtD
Zafirlukast—Sinusitis—Progesterone—uterine cancer	0.00104	0.0071	CcSEcCtD
Zafirlukast—Haemoglobin—Progesterone—uterine cancer	0.000999	0.00683	CcSEcCtD
Zafirlukast—Haemorrhage—Progesterone—uterine cancer	0.000994	0.00679	CcSEcCtD
Zafirlukast—Hepatitis—Progesterone—uterine cancer	0.000994	0.00679	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.000984	0.00672	CcSEcCtD
Zafirlukast—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.000978	0.00668	CcSEcCtD
Zafirlukast—Neuropathy—Etoposide—uterine cancer	0.000951	0.0065	CcSEcCtD
Zafirlukast—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.000941	0.00643	CcSEcCtD
Zafirlukast—Liver function test abnormal—Dactinomycin—uterine cancer	0.000938	0.00641	CcSEcCtD
Zafirlukast—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000905	0.00619	CcSEcCtD
Zafirlukast—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.000901	0.00616	CcSEcCtD
Zafirlukast—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.000901	0.00616	CcSEcCtD
Zafirlukast—ABCG2—uterine cervix—uterine cancer	0.000862	0.0188	CbGeAlD
Zafirlukast—Back pain—Progesterone—uterine cancer	0.000837	0.00572	CcSEcCtD
Zafirlukast—Swelling—Etoposide—uterine cancer	0.000833	0.00569	CcSEcCtD
Zafirlukast—CYP2C8—renal system—uterine cancer	0.000829	0.0181	CbGeAlD
Zafirlukast—ABCG2—decidua—uterine cancer	0.000821	0.0179	CbGeAlD
Zafirlukast—Neutropenia—Dactinomycin—uterine cancer	0.000821	0.00561	CcSEcCtD
Zafirlukast—Haematemesis—Epirubicin—uterine cancer	0.000817	0.00558	CcSEcCtD
Zafirlukast—Ill-defined disorder—Progesterone—uterine cancer	0.000803	0.00549	CcSEcCtD
Zafirlukast—CYP2C8—endometrium—uterine cancer	0.000801	0.0175	CbGeAlD
Zafirlukast—Angioedema—Progesterone—uterine cancer	0.000791	0.0054	CcSEcCtD
Zafirlukast—Blister—Epirubicin—uterine cancer	0.000787	0.00538	CcSEcCtD
Zafirlukast—Malaise—Progesterone—uterine cancer	0.00078	0.00533	CcSEcCtD
Zafirlukast—ABCG2—endometrium—uterine cancer	0.000779	0.017	CbGeAlD
Zafirlukast—CYP1A2—renal system—uterine cancer	0.000776	0.0169	CbGeAlD
Zafirlukast—Haemoptysis—Epirubicin—uterine cancer	0.000767	0.00524	CcSEcCtD
Zafirlukast—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.000758	0.00518	CcSEcCtD
Zafirlukast—Haematemesis—Doxorubicin—uterine cancer	0.000756	0.00517	CcSEcCtD
Zafirlukast—ABCG2—mammalian vulva—uterine cancer	0.000754	0.0164	CbGeAlD
Zafirlukast—Arthralgia—Progesterone—uterine cancer	0.000737	0.00503	CcSEcCtD
Zafirlukast—Myalgia—Progesterone—uterine cancer	0.000737	0.00503	CcSEcCtD
Zafirlukast—Agranulocytosis—Dactinomycin—uterine cancer	0.00073	0.00499	CcSEcCtD
Zafirlukast—Blister—Doxorubicin—uterine cancer	0.000729	0.00498	CcSEcCtD
Zafirlukast—Discomfort—Progesterone—uterine cancer	0.000728	0.00497	CcSEcCtD
Zafirlukast—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000727	0.00497	CcSEcCtD
Zafirlukast—PTGS1—epithelium—uterine cancer	0.000725	0.0158	CbGeAlD
Zafirlukast—PTGS1—uterine cervix—uterine cancer	0.000719	0.0157	CbGeAlD
Zafirlukast—ABCG2—uterus—uterine cancer	0.000718	0.0157	CbGeAlD
Zafirlukast—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000716	0.0049	CcSEcCtD
Zafirlukast—Haemoptysis—Doxorubicin—uterine cancer	0.00071	0.00485	CcSEcCtD
Zafirlukast—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000707	0.00483	CcSEcCtD
Zafirlukast—Oedema—Progesterone—uterine cancer	0.000706	0.00483	CcSEcCtD
Zafirlukast—Hepatitis—Dactinomycin—uterine cancer	0.000703	0.0048	CcSEcCtD
Zafirlukast—Infection—Progesterone—uterine cancer	0.000702	0.00479	CcSEcCtD
Zafirlukast—PTGS1—smooth muscle tissue—uterine cancer	0.000698	0.0152	CbGeAlD
Zafirlukast—CYP2E1—renal system—uterine cancer	0.000698	0.0152	CbGeAlD
Zafirlukast—CYP2C19—vagina—uterine cancer	0.000688	0.015	CbGeAlD
Zafirlukast—Blood disorder—Epirubicin—uterine cancer	0.00068	0.00464	CcSEcCtD
Zafirlukast—Liver injury—Epirubicin—uterine cancer	0.000675	0.00461	CcSEcCtD
Zafirlukast—PTGS1—renal system—uterine cancer	0.000672	0.0147	CbGeAlD
Zafirlukast—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000668	0.00456	CcSEcCtD
Zafirlukast—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000668	0.00456	CcSEcCtD
Zafirlukast—CYP2C8—female reproductive system—uterine cancer	0.000664	0.0145	CbGeAlD
Zafirlukast—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00066	0.00451	CcSEcCtD
Zafirlukast—PTGS1—endometrium—uterine cancer	0.00065	0.0142	CbGeAlD
Zafirlukast—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000643	0.0044	CcSEcCtD
Zafirlukast—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00064	0.00437	CcSEcCtD
Zafirlukast—Insomnia—Progesterone—uterine cancer	0.000639	0.00437	CcSEcCtD
Zafirlukast—Infection—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.00434	CcSEcCtD
Zafirlukast—Blood disorder—Doxorubicin—uterine cancer	0.000629	0.0043	CcSEcCtD
Zafirlukast—PTGS1—mammalian vulva—uterine cancer	0.000629	0.0137	CbGeAlD
Zafirlukast—Rectal haemorrhage—Epirubicin—uterine cancer	0.000628	0.00429	CcSEcCtD
Zafirlukast—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000627	0.00428	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.000624	0.00427	CcSEcCtD
Zafirlukast—Liver injury—Doxorubicin—uterine cancer	0.000624	0.00427	CcSEcCtD
Zafirlukast—Dyspepsia—Progesterone—uterine cancer	0.000622	0.00425	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Progesterone—uterine cancer	0.00061	0.00417	CcSEcCtD
Zafirlukast—Fatigue—Progesterone—uterine cancer	0.000609	0.00416	CcSEcCtD
Zafirlukast—Pain—Progesterone—uterine cancer	0.000604	0.00413	CcSEcCtD
Zafirlukast—CYP2C8—vagina—uterine cancer	0.0006	0.0131	CbGeAlD
Zafirlukast—PTGS1—uterus—uterine cancer	0.000599	0.0131	CbGeAlD
Zafirlukast—Neutropenia—Etoposide—uterine cancer	0.000594	0.00406	CcSEcCtD
Zafirlukast—CYP2C9—female reproductive system—uterine cancer	0.00059	0.0129	CbGeAlD
Zafirlukast—ABCG2—female gonad—uterine cancer	0.000587	0.0128	CbGeAlD
Zafirlukast—ABCG2—vagina—uterine cancer	0.000584	0.0127	CbGeAlD
Zafirlukast—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000583	0.00398	CcSEcCtD
Zafirlukast—Feeling abnormal—Progesterone—uterine cancer	0.000582	0.00398	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Doxorubicin—uterine cancer	0.000581	0.00397	CcSEcCtD
Zafirlukast—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000579	0.00396	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.000578	0.00395	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Progesterone—uterine cancer	0.000577	0.00395	CcSEcCtD
Zafirlukast—Ill-defined disorder—Dactinomycin—uterine cancer	0.000567	0.00388	CcSEcCtD
Zafirlukast—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000563	0.00385	CcSEcCtD
Zafirlukast—CYP3A4—renal system—uterine cancer	0.000561	0.0122	CbGeAlD
Zafirlukast—Urticaria—Progesterone—uterine cancer	0.000561	0.00383	CcSEcCtD
Zafirlukast—CYP2E1—female reproductive system—uterine cancer	0.000559	0.0122	CbGeAlD
Zafirlukast—Body temperature increased—Progesterone—uterine cancer	0.000558	0.00382	CcSEcCtD
Zafirlukast—Abdominal pain—Progesterone—uterine cancer	0.000558	0.00382	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Etoposide—uterine cancer	0.000555	0.00379	CcSEcCtD
Zafirlukast—CYP2D6—renal system—uterine cancer	0.000552	0.0121	CbGeAlD
Zafirlukast—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000552	0.00378	CcSEcCtD
Zafirlukast—Jaundice—Etoposide—uterine cancer	0.000552	0.00377	CcSEcCtD
Zafirlukast—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000552	0.00377	CcSEcCtD
Zafirlukast—Malaise—Dactinomycin—uterine cancer	0.000552	0.00377	CcSEcCtD
Zafirlukast—Influenza like illness—Epirubicin—uterine cancer	0.000551	0.00377	CcSEcCtD
Zafirlukast—PTGS1—female reproductive system—uterine cancer	0.000538	0.0117	CbGeAlD
Zafirlukast—Neuropathy—Epirubicin—uterine cancer	0.000533	0.00364	CcSEcCtD
Zafirlukast—Agranulocytosis—Etoposide—uterine cancer	0.000529	0.00361	CcSEcCtD
Zafirlukast—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000527	0.0036	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000523	0.00358	CcSEcCtD
Zafirlukast—Myalgia—Dactinomycin—uterine cancer	0.000521	0.00356	CcSEcCtD
Zafirlukast—Hypersensitivity—Progesterone—uterine cancer	0.00052	0.00356	CcSEcCtD
Zafirlukast—Discomfort—Dactinomycin—uterine cancer	0.000514	0.00352	CcSEcCtD
Zafirlukast—Influenza like illness—Doxorubicin—uterine cancer	0.00051	0.00349	CcSEcCtD
Zafirlukast—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000508	0.00347	CcSEcCtD
Zafirlukast—Asthenia—Progesterone—uterine cancer	0.000507	0.00346	CcSEcCtD
Zafirlukast—Hypoaesthesia—Etoposide—uterine cancer	0.000506	0.00346	CcSEcCtD
Zafirlukast—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000506	0.00346	CcSEcCtD
Zafirlukast—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000506	0.00346	CcSEcCtD
Zafirlukast—Pruritus—Progesterone—uterine cancer	0.0005	0.00341	CcSEcCtD
Zafirlukast—Oedema—Dactinomycin—uterine cancer	0.000499	0.00341	CcSEcCtD
Zafirlukast—Infection—Dactinomycin—uterine cancer	0.000496	0.00339	CcSEcCtD
Zafirlukast—Neuropathy—Doxorubicin—uterine cancer	0.000493	0.00337	CcSEcCtD
Zafirlukast—PTGS1—female gonad—uterine cancer	0.00049	0.0107	CbGeAlD
Zafirlukast—Thrombocytopenia—Dactinomycin—uterine cancer	0.000489	0.00334	CcSEcCtD
Zafirlukast—PTGS1—vagina—uterine cancer	0.000487	0.0106	CbGeAlD
Zafirlukast—Diarrhoea—Progesterone—uterine cancer	0.000483	0.0033	CcSEcCtD
Zafirlukast—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000471	0.00322	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Epirubicin—uterine cancer	0.000471	0.00322	CcSEcCtD
Zafirlukast—Dizziness—Progesterone—uterine cancer	0.000467	0.00319	CcSEcCtD
Zafirlukast—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000459	0.00314	CcSEcCtD
Zafirlukast—Hepatic failure—Epirubicin—uterine cancer	0.000458	0.00313	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000455	0.00311	CcSEcCtD
Zafirlukast—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000453	0.00309	CcSEcCtD
Zafirlukast—CYP3A4—female reproductive system—uterine cancer	0.00045	0.00981	CbGeAlD
Zafirlukast—Vomiting—Progesterone—uterine cancer	0.000449	0.00307	CcSEcCtD
Zafirlukast—Rash—Progesterone—uterine cancer	0.000445	0.00304	CcSEcCtD
Zafirlukast—Dermatitis—Progesterone—uterine cancer	0.000445	0.00304	CcSEcCtD
Zafirlukast—CYP2D6—female reproductive system—uterine cancer	0.000442	0.00965	CbGeAlD
Zafirlukast—Headache—Progesterone—uterine cancer	0.000442	0.00302	CcSEcCtD
Zafirlukast—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000438	0.00299	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000436	0.00298	CcSEcCtD
Zafirlukast—Dermatitis bullous—Epirubicin—uterine cancer	0.000431	0.00295	CcSEcCtD
Zafirlukast—Fatigue—Dactinomycin—uterine cancer	0.00043	0.00294	CcSEcCtD
Zafirlukast—Back pain—Etoposide—uterine cancer	0.000428	0.00293	CcSEcCtD
Zafirlukast—Pain—Dactinomycin—uterine cancer	0.000427	0.00292	CcSEcCtD
Zafirlukast—Hepatic failure—Doxorubicin—uterine cancer	0.000424	0.0029	CcSEcCtD
Zafirlukast—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000423	0.00289	CcSEcCtD
Zafirlukast—Nausea—Progesterone—uterine cancer	0.000419	0.00287	CcSEcCtD
Zafirlukast—Feeling abnormal—Dactinomycin—uterine cancer	0.000411	0.00281	CcSEcCtD
Zafirlukast—Ill-defined disorder—Etoposide—uterine cancer	0.000411	0.00281	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000408	0.00279	CcSEcCtD
Zafirlukast—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000407	0.00278	CcSEcCtD
Zafirlukast—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000403	0.00276	CcSEcCtD
Zafirlukast—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000403	0.00276	CcSEcCtD
Zafirlukast—CYP2D6—female gonad—uterine cancer	0.000403	0.00878	CbGeAlD
Zafirlukast—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000401	0.00274	CcSEcCtD
Zafirlukast—Malaise—Etoposide—uterine cancer	0.000399	0.00273	CcSEcCtD
Zafirlukast—Dermatitis bullous—Doxorubicin—uterine cancer	0.000399	0.00273	CcSEcCtD
Zafirlukast—Body temperature increased—Dactinomycin—uterine cancer	0.000395	0.0027	CcSEcCtD
Zafirlukast—Abdominal pain—Dactinomycin—uterine cancer	0.000395	0.0027	CcSEcCtD
Zafirlukast—Liver function test abnormal—Epirubicin—uterine cancer	0.00038	0.0026	CcSEcCtD
Zafirlukast—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00038	0.0026	CcSEcCtD
Zafirlukast—ABCG2—lymph node—uterine cancer	0.000378	0.00824	CbGeAlD
Zafirlukast—Discomfort—Etoposide—uterine cancer	0.000372	0.00254	CcSEcCtD
Zafirlukast—Hypersensitivity—Dactinomycin—uterine cancer	0.000368	0.00251	CcSEcCtD
Zafirlukast—Infection—Etoposide—uterine cancer	0.000359	0.00245	CcSEcCtD
Zafirlukast—Asthenia—Dactinomycin—uterine cancer	0.000358	0.00245	CcSEcCtD
Zafirlukast—Thrombocytopenia—Etoposide—uterine cancer	0.000354	0.00242	CcSEcCtD
Zafirlukast—Eosinophilia—Epirubicin—uterine cancer	0.000353	0.00241	CcSEcCtD
Zafirlukast—Liver function test abnormal—Doxorubicin—uterine cancer	0.000352	0.00241	CcSEcCtD
Zafirlukast—Diarrhoea—Dactinomycin—uterine cancer	0.000342	0.00233	CcSEcCtD
Zafirlukast—Neutropenia—Epirubicin—uterine cancer	0.000333	0.00228	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—uterine cancer	0.000326	0.00223	CcSEcCtD
Zafirlukast—Vomiting—Dactinomycin—uterine cancer	0.000317	0.00217	CcSEcCtD
Zafirlukast—PTGS1—lymph node—uterine cancer	0.000315	0.00687	CbGeAlD
Zafirlukast—Rash—Dactinomycin—uterine cancer	0.000315	0.00215	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Etoposide—uterine cancer	0.000312	0.00213	CcSEcCtD
Zafirlukast—Fatigue—Etoposide—uterine cancer	0.000311	0.00213	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Epirubicin—uterine cancer	0.000311	0.00213	CcSEcCtD
Zafirlukast—Jaundice—Epirubicin—uterine cancer	0.000309	0.00212	CcSEcCtD
Zafirlukast—Pain—Etoposide—uterine cancer	0.000309	0.00211	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—uterine cancer	0.000308	0.00211	CcSEcCtD
Zafirlukast—Sinusitis—Epirubicin—uterine cancer	0.000298	0.00204	CcSEcCtD
Zafirlukast—Feeling abnormal—Etoposide—uterine cancer	0.000298	0.00203	CcSEcCtD
Zafirlukast—Nausea—Dactinomycin—uterine cancer	0.000296	0.00203	CcSEcCtD
Zafirlukast—Agranulocytosis—Epirubicin—uterine cancer	0.000296	0.00203	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Etoposide—uterine cancer	0.000295	0.00202	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000288	0.00197	CcSEcCtD
Zafirlukast—Urticaria—Etoposide—uterine cancer	0.000287	0.00196	CcSEcCtD
Zafirlukast—Haemoglobin—Epirubicin—uterine cancer	0.000286	0.00196	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—uterine cancer	0.000286	0.00196	CcSEcCtD
Zafirlukast—Body temperature increased—Etoposide—uterine cancer	0.000286	0.00195	CcSEcCtD
Zafirlukast—Abdominal pain—Etoposide—uterine cancer	0.000286	0.00195	CcSEcCtD
Zafirlukast—Haemorrhage—Epirubicin—uterine cancer	0.000285	0.00195	CcSEcCtD
Zafirlukast—Hepatitis—Epirubicin—uterine cancer	0.000285	0.00195	CcSEcCtD
Zafirlukast—Hypoaesthesia—Epirubicin—uterine cancer	0.000284	0.00194	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—uterine cancer	0.000276	0.00188	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—uterine cancer	0.000274	0.00187	CcSEcCtD
Zafirlukast—Hypersensitivity—Etoposide—uterine cancer	0.000266	0.00182	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—uterine cancer	0.000265	0.00181	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—uterine cancer	0.000264	0.0018	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—uterine cancer	0.000264	0.0018	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—uterine cancer	0.000262	0.00179	CcSEcCtD
Zafirlukast—Asthenia—Etoposide—uterine cancer	0.000259	0.00177	CcSEcCtD
Zafirlukast—Pruritus—Etoposide—uterine cancer	0.000256	0.00175	CcSEcCtD
Zafirlukast—Diarrhoea—Etoposide—uterine cancer	0.000247	0.00169	CcSEcCtD
Zafirlukast—Back pain—Epirubicin—uterine cancer	0.00024	0.00164	CcSEcCtD
Zafirlukast—Dizziness—Etoposide—uterine cancer	0.000239	0.00163	CcSEcCtD
Zafirlukast—Ill-defined disorder—Epirubicin—uterine cancer	0.00023	0.00157	CcSEcCtD
Zafirlukast—Vomiting—Etoposide—uterine cancer	0.00023	0.00157	CcSEcCtD
Zafirlukast—Rash—Etoposide—uterine cancer	0.000228	0.00156	CcSEcCtD
Zafirlukast—Dermatitis—Etoposide—uterine cancer	0.000228	0.00156	CcSEcCtD
Zafirlukast—Headache—Etoposide—uterine cancer	0.000226	0.00155	CcSEcCtD
Zafirlukast—Malaise—Epirubicin—uterine cancer	0.000224	0.00153	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—uterine cancer	0.000222	0.00152	CcSEcCtD
Zafirlukast—Nausea—Etoposide—uterine cancer	0.000215	0.00147	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—uterine cancer	0.000213	0.00146	CcSEcCtD
Zafirlukast—Myalgia—Epirubicin—uterine cancer	0.000211	0.00144	CcSEcCtD
Zafirlukast—Arthralgia—Epirubicin—uterine cancer	0.000211	0.00144	CcSEcCtD
Zafirlukast—Discomfort—Epirubicin—uterine cancer	0.000209	0.00143	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—uterine cancer	0.000207	0.00141	CcSEcCtD
Zafirlukast—Oedema—Epirubicin—uterine cancer	0.000202	0.00138	CcSEcCtD
Zafirlukast—Infection—Epirubicin—uterine cancer	0.000201	0.00137	CcSEcCtD
Zafirlukast—Thrombocytopenia—Epirubicin—uterine cancer	0.000198	0.00136	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—uterine cancer	0.000195	0.00134	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—uterine cancer	0.000195	0.00134	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—uterine cancer	0.000193	0.00132	CcSEcCtD
Zafirlukast—Oedema—Doxorubicin—uterine cancer	0.000187	0.00128	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—uterine cancer	0.000186	0.00127	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000184	0.00126	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—uterine cancer	0.000183	0.00125	CcSEcCtD
Zafirlukast—Insomnia—Epirubicin—uterine cancer	0.000183	0.00125	CcSEcCtD
Zafirlukast—Dyspepsia—Epirubicin—uterine cancer	0.000178	0.00122	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000175	0.00119	CcSEcCtD
Zafirlukast—Fatigue—Epirubicin—uterine cancer	0.000175	0.00119	CcSEcCtD
Zafirlukast—Pain—Epirubicin—uterine cancer	0.000173	0.00118	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000171	0.00117	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—uterine cancer	0.000169	0.00116	CcSEcCtD
Zafirlukast—Feeling abnormal—Epirubicin—uterine cancer	0.000167	0.00114	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Epirubicin—uterine cancer	0.000166	0.00113	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—uterine cancer	0.000165	0.00113	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000162	0.00111	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—uterine cancer	0.000162	0.0011	CcSEcCtD
Zafirlukast—Urticaria—Epirubicin—uterine cancer	0.000161	0.0011	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—uterine cancer	0.00016	0.0011	CcSEcCtD
Zafirlukast—Abdominal pain—Epirubicin—uterine cancer	0.00016	0.00109	CcSEcCtD
Zafirlukast—Body temperature increased—Epirubicin—uterine cancer	0.00016	0.00109	CcSEcCtD
Zafirlukast—Feeling abnormal—Doxorubicin—uterine cancer	0.000154	0.00106	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000153	0.00105	CcSEcCtD
Zafirlukast—Hypersensitivity—Epirubicin—uterine cancer	0.000149	0.00102	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—uterine cancer	0.000149	0.00102	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—uterine cancer	0.000148	0.00101	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—uterine cancer	0.000148	0.00101	CcSEcCtD
Zafirlukast—Asthenia—Epirubicin—uterine cancer	0.000145	0.000993	CcSEcCtD
Zafirlukast—Pruritus—Epirubicin—uterine cancer	0.000143	0.000979	CcSEcCtD
Zafirlukast—Diarrhoea—Epirubicin—uterine cancer	0.000139	0.000947	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—uterine cancer	0.000138	0.000943	CcSEcCtD
Zafirlukast—Asthenia—Doxorubicin—uterine cancer	0.000134	0.000919	CcSEcCtD
Zafirlukast—Dizziness—Epirubicin—uterine cancer	0.000134	0.000915	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—uterine cancer	0.000133	0.000906	CcSEcCtD
Zafirlukast—Vomiting—Epirubicin—uterine cancer	0.000129	0.00088	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—uterine cancer	0.000128	0.000876	CcSEcCtD
Zafirlukast—Rash—Epirubicin—uterine cancer	0.000128	0.000873	CcSEcCtD
Zafirlukast—Dermatitis—Epirubicin—uterine cancer	0.000128	0.000872	CcSEcCtD
Zafirlukast—Headache—Epirubicin—uterine cancer	0.000127	0.000867	CcSEcCtD
Zafirlukast—Dizziness—Doxorubicin—uterine cancer	0.000124	0.000847	CcSEcCtD
Zafirlukast—Nausea—Epirubicin—uterine cancer	0.00012	0.000822	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—uterine cancer	0.000119	0.000814	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—uterine cancer	0.000118	0.000807	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—uterine cancer	0.000118	0.000807	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—uterine cancer	0.000117	0.000802	CcSEcCtD
Zafirlukast—Nausea—Doxorubicin—uterine cancer	0.000111	0.000761	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CXCL8—uterine cancer	3e-05	0.0016	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.99e-05	0.00159	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—FGFR2—uterine cancer	2.97e-05	0.00159	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.92e-05	0.00156	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.88e-05	0.00154	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.85e-05	0.00152	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.85e-05	0.00152	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.79e-05	0.00149	CbGpPWpGaD
Zafirlukast—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.75e-05	0.00147	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.72e-05	0.00145	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STK11—uterine cancer	2.64e-05	0.00141	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL2—uterine cancer	2.63e-05	0.0014	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.57e-05	0.00137	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.57e-05	0.00137	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ESR1—uterine cancer	2.54e-05	0.00136	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—STAR—uterine cancer	2.51e-05	0.00134	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKR1B1—uterine cancer	2.51e-05	0.00134	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NDUFB11—uterine cancer	2.49e-05	0.00133	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SRD5A2—uterine cancer	2.49e-05	0.00133	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SOCS3—uterine cancer	2.47e-05	0.00132	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.43e-05	0.0013	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.43e-05	0.0013	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—STAR—uterine cancer	2.41e-05	0.00129	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKR1B1—uterine cancer	2.41e-05	0.00129	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—NRAS—uterine cancer	2.4e-05	0.00128	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.38e-05	0.00127	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CDKN2B—uterine cancer	2.37e-05	0.00126	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IGF1R—uterine cancer	2.3e-05	0.00123	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.29e-05	0.00122	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCL8—uterine cancer	2.29e-05	0.00122	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL2—uterine cancer	2.24e-05	0.0012	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.18e-05	0.00117	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SMAD3—uterine cancer	2.16e-05	0.00115	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.15e-05	0.00115	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.15e-05	0.00115	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.15e-05	0.00115	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.12e-05	0.00113	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—PIK3CA—uterine cancer	2.09e-05	0.00112	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.09e-05	0.00112	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.09e-05	0.00111	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCL8—uterine cancer	2.08e-05	0.00111	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—KRAS—uterine cancer	2.07e-05	0.0011	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—FGFR2—uterine cancer	2.06e-05	0.0011	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.98e-05	0.00105	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—POLD1—uterine cancer	1.97e-05	0.00105	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.92e-05	0.00103	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.92e-05	0.00103	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—PIK3CA—uterine cancer	1.9e-05	0.00101	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—POLD1—uterine cancer	1.89e-05	0.00101	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—ERBB2—uterine cancer	1.87e-05	0.000996	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.87e-05	0.000996	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKR1C1—uterine cancer	1.84e-05	0.000983	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKR1B1—uterine cancer	1.8e-05	0.000961	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—STAR—uterine cancer	1.8e-05	0.000961	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.78e-05	0.000952	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCL8—uterine cancer	1.77e-05	0.000945	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKR1C1—uterine cancer	1.77e-05	0.000944	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.77e-05	0.000943	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.77e-05	0.000943	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ESR1—uterine cancer	1.76e-05	0.000941	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.76e-05	0.000941	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HRAS—uterine cancer	1.76e-05	0.000939	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.75e-05	0.000935	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.75e-05	0.000935	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CDKN1B—uterine cancer	1.73e-05	0.000923	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AKT1—uterine cancer	1.71e-05	0.000913	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.7e-05	0.000908	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—NRAS—uterine cancer	1.67e-05	0.000889	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—RRM2—uterine cancer	1.64e-05	0.000876	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CTNNB1—uterine cancer	1.63e-05	0.000872	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.61e-05	0.000858	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—DCN—uterine cancer	1.59e-05	0.00085	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTEN—uterine cancer	1.59e-05	0.00085	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—RRM2—uterine cancer	1.58e-05	0.000841	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—STAR—uterine cancer	1.56e-05	0.000831	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.56e-05	0.000831	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AKT1—uterine cancer	1.55e-05	0.000829	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL2—uterine cancer	1.55e-05	0.000828	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.54e-05	0.000821	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—DCN—uterine cancer	1.53e-05	0.000817	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—EP300—uterine cancer	1.52e-05	0.00081	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP11A1—uterine cancer	1.5e-05	0.000801	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.5e-05	0.000799	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.5e-05	0.000799	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.45e-05	0.000776	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—PIK3CA—uterine cancer	1.45e-05	0.000774	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP11A1—uterine cancer	1.44e-05	0.00077	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—VEGFA—uterine cancer	1.44e-05	0.000767	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—KRAS—uterine cancer	1.43e-05	0.000766	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NRAS—uterine cancer	1.42e-05	0.000758	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKR1C3—uterine cancer	1.42e-05	0.000756	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—POLD1—uterine cancer	1.41e-05	0.000754	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.39e-05	0.000742	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—STAR—uterine cancer	1.39e-05	0.000742	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.37e-05	0.000733	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.37e-05	0.000733	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKR1C3—uterine cancer	1.36e-05	0.000727	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.32e-05	0.000705	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PIK3CA—uterine cancer	1.32e-05	0.000703	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—ERBB2—uterine cancer	1.29e-05	0.000691	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—STAR—uterine cancer	1.28e-05	0.000682	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.28e-05	0.000682	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.27e-05	0.000676	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—STAR—uterine cancer	1.27e-05	0.000676	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.25e-05	0.000668	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL8—uterine cancer	1.23e-05	0.000655	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—KRAS—uterine cancer	1.22e-05	0.000652	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—POLD1—uterine cancer	1.22e-05	0.000652	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HRAS—uterine cancer	1.22e-05	0.000651	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CDKN1B—uterine cancer	1.2e-05	0.00064	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AKT1—uterine cancer	1.19e-05	0.000633	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—RRM2—uterine cancer	1.18e-05	0.000629	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.16e-05	0.000617	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.16e-05	0.000617	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—DCN—uterine cancer	1.14e-05	0.00061	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.14e-05	0.00061	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CTNNB1—uterine cancer	1.13e-05	0.000604	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PIK3CA—uterine cancer	1.12e-05	0.000599	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—STK11—uterine cancer	1.1e-05	0.000589	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP19A1—uterine cancer	1.1e-05	0.000589	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTEN—uterine cancer	1.1e-05	0.000589	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—POLD1—uterine cancer	1.09e-05	0.000582	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—uterine cancer	1.09e-05	0.00058	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.08e-05	0.000578	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—STAR—uterine cancer	1.08e-05	0.000578	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.08e-05	0.000575	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AKT1—uterine cancer	1.08e-05	0.000575	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.07e-05	0.000571	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP19A1—uterine cancer	1.06e-05	0.000566	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—STK11—uterine cancer	1.06e-05	0.000566	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—EP300—uterine cancer	1.05e-05	0.000562	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HRAS—uterine cancer	1.04e-05	0.000555	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.02e-05	0.000544	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—RRM2—uterine cancer	1.02e-05	0.000544	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.02e-05	0.000543	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—POLD1—uterine cancer	1e-05	0.000535	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—VEGFA—uterine cancer	9.97e-06	0.000532	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.96e-06	0.000531	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—POLD1—uterine cancer	9.94e-06	0.000531	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—DCN—uterine cancer	9.89e-06	0.000528	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NRAS—uterine cancer	9.85e-06	0.000525	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.5e-06	0.000507	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKR1C1—uterine cancer	9.38e-06	0.000501	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP11A1—uterine cancer	9.31e-06	0.000497	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKR1C1—uterine cancer	9.3e-06	0.000496	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AKT1—uterine cancer	9.18e-06	0.00049	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—RRM2—uterine cancer	9.09e-06	0.000485	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—DCN—uterine cancer	8.83e-06	0.000471	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKR1C3—uterine cancer	8.8e-06	0.000469	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—POLD1—uterine cancer	8.5e-06	0.000453	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—KRAS—uterine cancer	8.47e-06	0.000452	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—RRM2—uterine cancer	8.36e-06	0.000446	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKR1B1—uterine cancer	8.36e-06	0.000446	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—STAR—uterine cancer	8.36e-06	0.000446	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP11A1—uterine cancer	8.31e-06	0.000444	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—MTHFR—uterine cancer	8.3e-06	0.000443	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—RRM2—uterine cancer	8.29e-06	0.000442	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—DCN—uterine cancer	8.12e-06	0.000433	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—DCN—uterine cancer	8.05e-06	0.000429	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—MTHFR—uterine cancer	7.97e-06	0.000425	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKR1C1—uterine cancer	7.95e-06	0.000424	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP19A1—uterine cancer	7.93e-06	0.000423	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—STK11—uterine cancer	7.93e-06	0.000423	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKR1C3—uterine cancer	7.85e-06	0.000419	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PIK3CA—uterine cancer	7.79e-06	0.000415	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP11A1—uterine cancer	7.65e-06	0.000408	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP11A1—uterine cancer	7.58e-06	0.000405	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—uterine cancer	7.53e-06	0.000402	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKR1C3—uterine cancer	7.22e-06	0.000385	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRAS—uterine cancer	7.2e-06	0.000384	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKR1C3—uterine cancer	7.16e-06	0.000382	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—RRM2—uterine cancer	7.08e-06	0.000378	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.03e-06	0.000375	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—DCN—uterine cancer	6.88e-06	0.000367	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—STK11—uterine cancer	6.85e-06	0.000366	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP19A1—uterine cancer	6.85e-06	0.000366	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—POLD1—uterine cancer	6.56e-06	0.00035	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.48e-06	0.000346	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.43e-06	0.000343	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—uterine cancer	6.36e-06	0.000339	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.13e-06	0.000327	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKR1C1—uterine cancer	6.13e-06	0.000327	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKR1C3—uterine cancer	6.12e-06	0.000326	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—STK11—uterine cancer	6.12e-06	0.000326	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP19A1—uterine cancer	6.12e-06	0.000326	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MTHFR—uterine cancer	5.96e-06	0.000318	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.74e-06	0.000306	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—STK11—uterine cancer	5.63e-06	0.0003	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP19A1—uterine cancer	5.63e-06	0.0003	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—STK11—uterine cancer	5.58e-06	0.000298	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP19A1—uterine cancer	5.58e-06	0.000298	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.48e-06	0.000292	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—RRM2—uterine cancer	5.47e-06	0.000292	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—DCN—uterine cancer	5.31e-06	0.000283	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.24e-06	0.000279	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MTHFR—uterine cancer	5.15e-06	0.000275	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP11A1—uterine cancer	5e-06	0.000267	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.99e-06	0.000266	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—STK11—uterine cancer	4.77e-06	0.000254	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.77e-06	0.000254	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.72e-06	0.000252	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—uterine cancer	4.62e-06	0.000246	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MTHFR—uterine cancer	4.6e-06	0.000245	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.54e-06	0.000242	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.47e-06	0.000239	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—uterine cancer	4.44e-06	0.000237	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—EP300—uterine cancer	4.4e-06	0.000235	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.27e-06	0.000228	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—EP300—uterine cancer	4.23e-06	0.000226	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MTHFR—uterine cancer	4.23e-06	0.000226	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MTHFR—uterine cancer	4.19e-06	0.000224	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.05e-06	0.000216	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.69e-06	0.000197	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—STK11—uterine cancer	3.68e-06	0.000196	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.68e-06	0.000196	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MTHFR—uterine cancer	3.58e-06	0.000191	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—uterine cancer	3.31e-06	0.000177	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PIK3CA—uterine cancer	3.26e-06	0.000174	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—EP300—uterine cancer	3.16e-06	0.000169	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.16e-06	0.000168	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PIK3CA—uterine cancer	3.13e-06	0.000167	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—uterine cancer	2.86e-06	0.000153	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MTHFR—uterine cancer	2.76e-06	0.000148	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—EP300—uterine cancer	2.73e-06	0.000146	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—uterine cancer	2.66e-06	0.000142	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—uterine cancer	2.56e-06	0.000136	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—uterine cancer	2.56e-06	0.000136	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—EP300—uterine cancer	2.44e-06	0.00013	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—uterine cancer	2.35e-06	0.000126	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.34e-06	0.000125	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—uterine cancer	2.33e-06	0.000124	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—EP300—uterine cancer	2.24e-06	0.00012	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—EP300—uterine cancer	2.22e-06	0.000119	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.02e-06	0.000108	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—uterine cancer	1.99e-06	0.000106	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—uterine cancer	1.91e-06	0.000102	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—EP300—uterine cancer	1.9e-06	0.000101	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.8e-06	9.63e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.66e-06	8.85e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—uterine cancer	1.65e-06	8.81e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.64e-06	8.78e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—uterine cancer	1.54e-06	8.21e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—uterine cancer	1.47e-06	7.86e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—EP300—uterine cancer	1.47e-06	7.83e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.41e-06	7.5e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—uterine cancer	1.36e-06	7.23e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—uterine cancer	1.34e-06	7.17e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—uterine cancer	1.15e-06	6.13e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.08e-06	5.79e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—uterine cancer	8.86e-07	4.73e-05	CbGpPWpGaD
